AFLD 2009 FFHMFAC vs Respondent M54

Facts
The French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme, FFHMFAC) charges respondent M54 for a violation of the Anti-Doping Rules. During a contest on March 21, 2009, a sample was taken for doping test purposes. The sample showed the presence of metabolites of metandienone, a metabolite of nandrolone, 17α-methyl-5β-androstane-3α,17β-diol and 17β-methyl-5β-androst-1-ene-3α,17α-diol. These substances are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent admits the use steroids.

Decision
1. The sanction is a period of ineligibility of six years in which respondent can't take part in competition or manifestations organized or authorized by French sport organizations.
2. All the results obtained at the event on March 21, 2009, are cancelled. Medals, points and prizes are withdrawn.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
17 December 2009
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Aggravating circumstances
Period of ineligibility
Sport/IFs
Powerlifting (IPF) - International Powerlifting Federation
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme (FFHMFAC) - French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding
Fédération Française de Force (FFForce) - French Powerlifting Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S1. Anabolic Agents
Substances
17α-methyl-5β-androstane-3α,17β-diol
17β-methyl-5β-androst-1-ene-3α,17α-diol
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Nandrolone (19-nortestosterone)
Document type
Pdf file
Date generated
19 June 2014
Date of last modification
13 February 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin